Novartis AG (ADR) (NVS)
$52.80
0.22 (+0.42%)
| CAPS Rating |
|
|---|---|
| Open | $52.33 |
| Previous Close | $52.58 |
| Daily Range | $52.30 - $52.81 |
| 52-Week Range | $33.34 - $52.92 |
| Market Cap | $119.58B |
| P/E Ratio | 14.65 |
| Dividend (Yield) | 1.45 (2.80%) |
| Volume | 1,175,455 |
| Average Daily Volume | 1,529,000 |
NVS
VS S&P 500 (SPY)
How do you think NVS will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
NVS Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
NVS News and Commentary
- CNBC on Novartis AG ADS – Ockham-RazorWire
- Eye on Insiders: Johnson & Johnson – The Motley Fool
- CNBC on Novartis AG ADS – Ockham-RazorWire
- You Don't Need Much to Start – The Motley Fool
- Nice Quarter, Teva. What Will You Buy Next? – The Motley Fool
- This Stable Stock Could Still Surprise – The Motley Fool
- Finally Convinced? Benlysta Works! – The Motley Fool
- Get Ready for the Fall? – The Motley Fool
- Winners and Losers of the House Health-Care Reform Bill – The Motley Fool
- Shrugging Off the Side Effects – The Motley Fool
- Earnings? Yawn. Trial Data? Moving! – The Motley Fool
- It's Not As Frightening As It First Appears – The Motley Fool
- Of One-Time Gains and Pipelines – The Motley Fool
- Should You Dump These Dividend Stocks? – The Motley Fool
- World's Scariest Stocks: Pfizer – The Motley Fool
- Eye on Insiders: Amgen – The Motley Fool
- The Winning Opportunity No One Talks About – The Motley Fool
- Half-Price Sale on 3 Great Stocks – The Motley Fool
- Pfizer's and Merck's Loss Is These Companies' Gain – The Motley Fool
- Here's When the Crash Will Happen – The Motley Fool
RSS Headlines
Fool UK
